Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alain Spatz

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Melanoma Research|May 17, 2007
F-18 fluorodeoxy-D-glucose positron emission tomography scan in the initial evaluation of patients with a primary melanoma thicker than 4 mmEve Maubec, Jean Lumbroso, Florence Masson, et al.
The Journal of Pathology|July 8, 2003
The development of optimal pathological assessment of sentinel lymph nodes for melanomaMartin G Cook, Margaret A Green, Brian Anderson, et al.
European Journal of Cancer (Oxford, England : 1990)|December 5, 2009
Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guidelineClaus Garbe, Ketty Peris, Axel Hauschild, et al.
Journal of Leukocyte Biology|July 1, 2006
Dendritic cell derived-exosomes: biology and clinical implementationsNathalie Chaput, Caroline Flament, Sophie Viaud, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 27, 2006
Expression and possible role of hPTTG1/securin in cutaneous malignant melanomaVéronique Winnepenninckx, Maria Debiec-Rychter, Jeroen A M Beliën, et al.
The Lancet. Oncology|July 5, 2005
Cutaneous side-effects of kinase inhibitors and blocking antibodiesCaroline Robert, Jean-Charles Soria, Alain Spatz, et al.
Cancer Research|March 18, 2004
Selective accumulation of mature DC-Lamp+ dendritic cells in tumor sites is associated with efficient T-cell-mediated antitumor response and control of metastatic dissemination in melanomaMojgan Movassagh, Alain Spatz, Jean Davoust, et al.
Familial Cancer|July 13, 2007
BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanomaChristian Monnerat, Agnès Chompret, Caroline Kannengiesser, et al.
Pigment Cell Research|January 14, 2004
Clinical and histopathological characterization of cutaneous melanomas in the melanoblastoma-bearing Libechov minipig modelSilvia Vincent-Naulleau, Catherine Le Chalony, Jean-Jacques Leplat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2010
Phase III trial comparing adjuvant treatment with pegylated interferon Alfa-2b versus observation: prognostic significance of autoantibodies--EORTC 18991Marna G Bouwhuis, Stefan Suciu, Alessandro Testori, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Melanoma Research|May 17, 2007
F-18 fluorodeoxy-D-glucose positron emission tomography scan in the initial evaluation of patients with a primary melanoma thicker than 4 mmEve Maubec, Jean Lumbroso, Florence Masson, et al.
The Journal of Pathology|July 8, 2003
The development of optimal pathological assessment of sentinel lymph nodes for melanomaMartin G Cook, Margaret A Green, Brian Anderson, et al.
European Journal of Cancer (Oxford, England : 1990)|December 5, 2009
Diagnosis and treatment of melanoma: European consensus-based interdisciplinary guidelineClaus Garbe, Ketty Peris, Axel Hauschild, et al.
Journal of Leukocyte Biology|July 1, 2006
Dendritic cell derived-exosomes: biology and clinical implementationsNathalie Chaput, Caroline Flament, Sophie Viaud, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 27, 2006
Expression and possible role of hPTTG1/securin in cutaneous malignant melanomaVéronique Winnepenninckx, Maria Debiec-Rychter, Jeroen A M Beliën, et al.
The Lancet. Oncology|July 5, 2005
Cutaneous side-effects of kinase inhibitors and blocking antibodiesCaroline Robert, Jean-Charles Soria, Alain Spatz, et al.
Cancer Research|March 18, 2004
Selective accumulation of mature DC-Lamp+ dendritic cells in tumor sites is associated with efficient T-cell-mediated antitumor response and control of metastatic dissemination in melanomaMojgan Movassagh, Alain Spatz, Jean Davoust, et al.
Familial Cancer|July 13, 2007
BRCA1, BRCA2, TP53, and CDKN2A germline mutations in patients with breast cancer and cutaneous melanomaChristian Monnerat, Agnès Chompret, Caroline Kannengiesser, et al.
Pigment Cell Research|January 14, 2004
Clinical and histopathological characterization of cutaneous melanomas in the melanoblastoma-bearing Libechov minipig modelSilvia Vincent-Naulleau, Catherine Le Chalony, Jean-Jacques Leplat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 14, 2010
Phase III trial comparing adjuvant treatment with pegylated interferon Alfa-2b versus observation: prognostic significance of autoantibodies--EORTC 18991Marna G Bouwhuis, Stefan Suciu, Alessandro Testori, et al.
Pageof 5